ASX:ILAPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
ISLAND PHARMACEUTICALS ORD
$0.400
+$0.025 (+6.67%)
Day Range
$0.400 - $0.400
52 Week Range
$0.130 - $0.630
Volume
4.00K
Avg Volume (10D)
167.37K
Market Cap
$118.37M
Price Chart
Market Statistics
Open$0.400
Previous Close$0.375
Day High$0.400
Day Low$0.400
52 Week High$0.630
52 Week Low$0.130
Valuation
Market Cap118.37M
Shares Outstanding295.92M
Price to Book14.66
Trading Activity
Volume4.00K
Value Traded1.60K
Bid$0.370 × 29,726
Ask$0.385 × 8,761
Performance
1 Day-1.27%
5 Day4.00%
13 Week0.00%
52 Week160.00%
YTD-9.30%
Technical Indicators
RSI (14)58.01
50-Day SMA$0.385
200-Day SMA$0.369
Latest News
Biotechnology
Island Pharma Expands Antiviral Pipeline with Burnet Institute Collaboration and NHMRC Funding
Island Pharma expands antiviral pipeline with Burnet Institute; NHMRC grant of over $780k to back ISLA-101, accelerating Galidesivir MVD program.
1 min read
Biotechnology
Island Pharma Partners with USAMRIID and Geneva Foundation for Galidesivir under FDA Animal Rule
Island Pharma signs a 3-year CRADA with USAMRIID and Geneva Foundation to fast-track Galidesivir for Marburg under FDA Animal Rule, eyeing NDA.
1 min read
Biotechnology
Island Pharmaceuticals Raises $9m to Fund Clinical Development as FDA Approves Galidesivir Pathway
Island Pharmaceuticals (ASX: ILA) secures FDA Animal Rule path for galidesivir and $9m funding to fast-track two-stage trials and US govt procurement potential.
1 min read
Biotechnology
Island Pharmaceuticals and Texas Biomed to Conduct Non-Human Primate Studies Using Antiviral Drug Galidesivir
Island Pharmaceuticals (ASX: ILA) has secured a master service agreement with Texas Biomedical Research Institute to support the development of lead antiviral molecule galidesivir.
1 min read